P-97 Updated results of HGCSG1603: A phase 2 trial of ramucirumab plus irinotecan combination therapy as second-line treatment for patients with advanced gastric cancer
| Autor: | Nakamura, M., Kawamoto, Y., Yuki, S., Sawada, K., Muto, O., Sogabe, S., Shindo, Y., Ishiguro, A., Sato, A., Tsuji, Y., Dazai, M., Okuda, H., Sasaki, T., Harada, K., Nakatsumi, H., Iuchi, K., Sakata, Y., Komatsu, Y. |
|---|---|
| Zdroj: | In Annals of Oncology July 2021 32 Supplement 3:S131-S131 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|